ICMR-developed vaccine targets two parasite stages, offers potential for long-term immunity and lower transmission ...

The first cycle of the 2025 Seasonal Malaria Chemoprevention campaign has started in Adamawa State. The exercise is aimed at ...

AdFalciVax is the first indigenous recombinant chimeric malaria vaccine specifically designed to target two critical stages ...

India will soon have an advanced vaccine against malaria. In a major scientific breakthrough, the Indian Council of Medical Research (ICMR) has developed an inn ...

For thousands of years malaria was a mysterious illness affecting people across the globe. Even the name of the disease, ‘malaria’, derived from two Italian words meaning ‘bad air’, highlights the ...

AdFalciVax is a unique malaria vaccine that targets two key stages of Plasmodium falciparum, the parasite responsible for the ...

India has taken a major step forward in the fight against malaria with the development of a new indigenous vaccine candidate called AdFalciVax.This vaccine is being developed by the Indian Council of ...

NII, is developing AdFalciVax—India’s first recombinant chimeric malaria vaccine. It targets two key stages of Plasmodium ...

Mosquitoes kill more people each year than any other animal. In 2023, the blood-sucking insects infected a reported 263 ...

Ivermectin administered to the whole population significantly reduces malaria transmission, offering new hope in the fight ...

Anemia and delayed antiretroviral therapy surfaced as drivers of increased viral load in pregnant women with HIV.

Ivermectin administered to the whole population significantly reduces malaria transmission, offering new hope in the fight against the disease.